Problem: The FDA has issued new standards governing the drug approval process. The enabling act authorizes the FDA to "act after a hearing." Inadaze Pharmaceuticals has challenged the validity of the new standards because the agency failed to hold a hearing on the record prior to finalizing the new standards. Does the challenge have merit? Why or why not?